Health Care • Medical/Nursing Services
$541.92 ▲ +8.56
(+1.61%)
MKT CAP: $7.08B • VOL: 193.6K
52W L $365 52W H $562
CHE // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.53B | $1.53B | $1.32B |
| YoY Revenue Growth % | +65.3% | +16.4% | — |
| Gross Profit | $823.2M | -$46.0M | $578.6M |
| Gross Margin % | 32.5% | -3.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $338.2M | $366.5M | $340.6M |
| Operating Margin % | 13.4% | 23.9% | 25.9% |
| Net Income (GAAP) | $265.2K | $302.0K | $272.5K |
| EBITDA (Normalized) | $388.5M | $406.1M | $387.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $388.3M | $417.5M | $330.3M |
| Capital Expenditures (CapEx) | $62.8M | $49.5M | $59.2M |
| Free Cash Flow (FCF) | $325.5M | $368.0M | $271.1M |
| FCF Margin % | 12.9% | 24.0% | 20.6% |
| Return on Invested Capital (ROIC %) | 23.1% | 24.4% | 11.4% |
| Cash & Short-Term Equivalents | $74.5M | $178.3M | $428.5M |
| Total Debt (Short + Long Term) | $251.5M | $247.3M | $911.6M |
| Total Stockholders' Equity | $979.4M | $1.12B | $1.87B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CHE.